Other Cardiovascular Effects of Wegovy The cardiovascular profile of semaglutide has been extensively studied, with generally favourable outcomes
What makes retatrutide different from other GLP-1s is that its a triple agonist, sometimes nicknamed triple G, because it targets three hormone pathways at the same time: GLP-1 (glucagon-like peptide-1): Found naturally in your gut, this hormone helps lower blood sugar by triggering insulin release and slowing down how fast food moves through the stomach, so you feel fuller for longer
2003 Jun-Aug;24(3-4):233-40
Developed by Eli Lilly, this medication is in a new class of weight loss treatments emerging alongside well-known options, such as semaglutide (Wegovy) and tirzepatide (Mounjaro)
Product ID:14678414
Whilst there is no established direct mechanism by which GLP-1 receptor agonists consistently cause joint pain, several indirect factors may explain why some patients experience musculoskeletal discomfort during treatment
